跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOGROYA somapacitan 5 mg (3.3 mg/mL) solution for injection prefilled pen - TGA Drug Approval Details
Approvals
/
TGA
/
SOGROYA somapacitan 5 mg (3.3 mg/mL) solution for injection prefilled pen
Approved
STANDARD
SOGROYA somapacitan 5 mg (3.3 mg/mL) solution for injection prefilled pen
Novo Nordisk Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9ceaecf6194a00c9
Company
Novo Nordisk Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
9ceaecf6194a00c9
Product Name
SOGROYA somapacitan 5 mg (3.3 mg/mL) solution for injection prefilled pen
Artg Id
396877
Artg Name
SOGROYA somapacitan 5 mg (3.3 mg/mL) solution for injection prefilled pen
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path
/organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date
2023-09-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9ceaecf6194a00c9
Type
Standard
Back to TGA Approvals